Sofosbuvir in combination with other antivirals safe for coronavirus
October 07, 2020 19:15 ISTResearchers have demonstrated that RNA terminated by hepatitis-C drug Sofosbuvir may be more effective against the Covid-19 virus.
Researchers have demonstrated that RNA terminated by hepatitis-C drug Sofosbuvir may be more effective against the Covid-19 virus.
Drug major Cipla today announced the launch of generic drug Sofosbuvir for treating chronic Hepatitis C under the brand name 'Hepcvir', in India."Following the non-exclusive licensing agreement signed with Gilead Sciences in September last year
Top News
Latest News
